Johan Sundström
Johan Sundström, MD, PhD is an expert in Cardiology at Uppsala University Hospital (Sweden). As of October 2026, ScienceLeadR ranks Johan Sundström in the top 1% of experts worldwide for Hypertension, Heart Failure and Glucose Metabolism Disorders. Johan Sundström has authored 603 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 4 of them ongoing. SLR score: 1,832 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Gastroenterology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Personal information
Name Sundström, Johan
Birth date 1971-03-17
IDs ORCID 0000-0003-2247-8454; ResearcherID IAP-6197-2023; Scopus 56702246400
Web uu.se/en/department/medical-sciences/research/research-groups/clinical-epidemiology; uu.se/awi; linkedin.com/in/drsundstrom
Publications https://www.ncbi.nlm.nih.gov/myncbi/1HmJPhYQKjmAV6/bibliography/public/
Education
2018-05-28 Specialist in Cardiology, Swedish National Board of Health and Welfare
2012-01-02 Specialist in Internal Medicine, Swedish National Board of Health and Welfare
2005-12-15 Associate Professor of Cardiovascular Epidemiology, Uppsala University, Sweden
2004-07-01 Medical License, Swedish National Board of Health and Welfare
2001-02-16 Doctor of Philosophy (PhD), Medical Faculty, Uppsala University, Sweden
1997-06-13 Medical Degree (MD), Karolinska Institutet, Sweden
Current employment
2015-04-01 Professor of Epidemiology, Department of Medical Sciences, Uppsala University
2025-01-01 Consultant in Cardiology, Department of Cardiology, Uppsala University Hospital
2023-09-04 Honorary Professor, The George Institute for Global Health, University of New South Wales, Sydney, Australia
Previous employment
2019-2023 Conjoint Professor, The George Institute for Global Health, University of New South Wales, Sydney, Australia
2014–2018 Scientific Director, Uppsala Clinical Research Center
2014–2015 Senior Lecturer in Epidemiology, Uppsala University
2018–2024 Cardiologist, Department of Cardiology, Uppsala University Hospital
2012–2018 Fellow, Department of Cardiology, Uppsala University Hospital
2004–2012 Resident, Department of Emergency Medicine, Uppsala University Hospital
2001–2004 Intern, Enköping Hospital/Uppsala University Hospital
1997–2001 Physician, Clinic for Obesity and Metabolic Diseases, Uppsala University Hospital
Fellowships
2012–2013 Visiting Professorial Fellow, The George Institute for Global Health, Sydney University, Sydney, Australia
2002–2003 Post-Doctoral Research Fellow, The Framingham Heart Study, Boston University, MA, USA
Supervision of graduate students and postdoctoral fellows
Principal supervisor for 9 ongoing PhD theses. Supervisor of 15 completed PhD theses; principal supervisor of 5 (Robert Bodén [dissertation 2010-03-26], Kasper Andersen [2014-03-21], Thomas Cars [2016-11-19], Gabriel Arefalk [2018-05-09], Yi-Ting Lin [2021-05-11]); co-supervisor of 10 (Erik Ingelsson [dissertation 2005-10-01], Christina Ström-Möller [2006-12-08], Martin Wohlin [2008-05-09], Bernice Wiberg [2010-05-11], Johan Sundelöf [2011-01-20], Susann Järhult [2010-12-15], Anna Alassaad [2014-12-11], Christoph Nowak [2017-05-22], Pål Hasvold [2018-02-13], Magnus Olsson [2026-02-13]). Mentored 11 post-docs; 9 part-time; 2 full-time (Per Lytsy [2012-2014], Jordan Loader [2020-2021]), and 3 ongoing.
Teaching activities
Responsible for the internal medicine education at Uppsala University Medical School. Responsible for development of artificial intelligence education, digital health education, evidence-based medicine education, and the master’s thesis course for medical students at Uppsala University Medical School. Past leader and developer of research methods courses compulsory for all PhD students at Uppsala University Medical Faculty. Regular supervisor in masters’ theses. Prior clinical assistant in clinical propedeutics. Nominated for the pedagogic award Munken, 2007. Founder of multiple seminar series for PhD students at the Department of Medical Sciences. Author of several medical textbook chapters, and one textbook (Handbok i biomedicinsk forskning, Liber förlag, ISBN 47-11399-6). Co-organizer of board-certified clinical specialist courses.
Scientific meeting activities
Organiser of multiple scientific meetings within the Swedish Epidemiological Society, EpiHealth, Cohorts.se, the Health Technology Assessment network, and Uppsala University. Invited speaker to several internationally established conferences and international advanced schools, including the European Society of Cardiology (ESC) Congress, the ESC Preventive Cardiology Congress, the European Public Health Conference, the European Society of Hypertension Summer School, the American Heart Association Scientific Sessions, and the Nordic University Research Course in Hypertension and Cardiovascular Disease.
Institutional responsibilities
2020– Founder and director of the Anders Wiklöf Institute for Heart Research, Uppsala University
2011– Board member, Department of Medical Sciences, Uppsala University
2015–2017 Board member of the Disciplinary Domain of Medicine and Pharmacy, Uppsala University
2014–2017 Deputy Head of the Department of Medical Sciences, Uppsala University
2011–2016 Chairman of the Board (Inspektor) of the College Västmanlands-Dala Nation at Uppsala University
2009–2011 Research Committee member, Department of Medical Sciences, Uppsala University
Commissions of trust and reviewing activities
2024– Board member of the Swedish Research Council's Committee for Clinical Therapy Research
2024– Board member of the Digital Health group, Swedish Society of Cardiology
2023– Scientific advisor to the French General Secretariat for Investment and the ministries of Health and Prevention and Research, France
2022– Initiator and member of National Working Group for hypertension in the National system for knowledge-driven management within Swedish healthcare
2020– Advisory board member for Cochrane Sweden
2011– Member of the regional health care advisory board for pharmaceutical treatment of hypertension
2011– Lead author of regional health care guidelines for the treatment of hypertension
2010– Scientific reviewer for the Ireland Health Research Board, the Danish Council for Independent Research, and the European Society of Cardiology
2017-2024 Head of the Health Technology Assessment unit at Region Uppsala
2007–2012 Chairman of the Board for the research foundation The Geriatric Fund
Examining committee member at multiple dissertations, and opponent at dissertations in Sweden, Norway, and Finland. Initiator and PI of the Swedish Cohort Consortium (Cohorts.se) and international myocardial infarction cohort consortium MIMI. Investigator in several randomized clinical trials; among those, initiator and PI of PHYSIC (NCT02774460); initiator and PI of U-SCREEN; initiator and PI of U-SCREEN-HF (NCT06940544); initiator and co-PI of SMARTEST (NCT03982381); national coordinator for APOLLO (NCT01259297). Steering committee member for large epidemiological studies SCAPIS (past PI for Uppsala), ULSAM, ROSE, ARBACE, ANDiU, Y2K (PI) and EpiHealth, and clinical trials REDUCe (NCT03278509) and START (NCT05345327).
Organizations
Career arc: 1996 - 2026
Number : 603
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Epidemiology of Uncontrolled and Treatment‑Resistant Hypertension: A Registry‑Based Observational Study. PMID 42872749 — registries, hypertension, comorbidity, epidemiology, blood, blood pressure, prevalence, diagnosis, therapeutics | Blood Press | 2026 | 0 |
| Global, Regional, and National Burden of Heart Failure, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023. PMID 42814432 — heart diseases, heart failure, heart, cardiovascular diseases, public health, global burden of disease, prevalence, cost of illness, chagas disease | JAMA Cardiol | 2026 | 0 |
| Effects of Polygenic Risk Scores and Physical Activity on Blood Pressure Trajectories in Childhood, Adolescence, and Young Adulthood. PMID 42779510 — exercise, longitudinal studies, blood, puberty, blood pressure, genetic risk score | Circ Genom Precis Med | 2026 | 0 |
| Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization. PMID 42755691 — liver diseases, hypertension, heart diseases, calcium channel blockers, heart failure, pharmaceutical preparations, heart, non-alcoholic fatty liver disease, blood pressure, renin, liver, antihypertensive agents, angiotensins, odds ratio, coronary disease, risk factors, therapeutics, fatty liver, random allocation, renin-angiotensin system, hemodynamics | Hypertension | 2026 | 0 |
| Snus, nicotine pouches and cardiovascular disease: Evidence, mechanisms, and the challenge of novel nicotine products. PMID 42706592 — tobacco, smokeless, internal medicine, cardiovascular diseases, nicotine, harm reduction | J Intern Med | 2026 | 0 |
Clinical Studies 13
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 6
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Uppsala Self Screening of Cardiovascular Health NCT07614659 — diabetes mellitus, kidney diseases, hypertension, blood, cardiovascular diseases, dyslipidemias, blood pressure, kidney, drug therapy, atrial fibrillation, biomarkers, aged, renal insufficiency, renal insufficiency, chronic, digital health | N/A | Recruiting | 2025 |
| Uppsala Self SCREENing of Heart Failure Study NCT06940544 — research design, quality of life, hospitalization, blood, point-of-care systems, heart failure, heart, heart failure, systolic, diagnosis, therapeutics, artificial intelligence, point-of-care testing | N/A | Recruiting | 2023 |
| OverTTuRe Characteristics Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis NCT06355934 — quality of life, activities of daily living, multiple chronic conditions, amyloidosis, therapeutics, data analysis, transthyretin amyloid cardiomyopathy, transthyretin amyloidosis | N/A | Recruiting | 2023 |
| Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY SYMPHONY HF NCT05919342 — registries, heart failure, heart, cardiovascular diseases, biomarkers, echocardiography, diagnosis, natriuretic peptides, therapeutics | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map